Inoviq Ltd has released a press release.
Australian Patent Granted for SubB2M Technology
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- INOVIQ Key Manufacturing Agreement to Advance SubB2M tests
- IIQ Appendix 4C & Quarterly Activities Report - March 2022
- INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests
- INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
- Update on Legal Proceedings and BARD1 Autoantibody Program
Later from Inoviq
- SubB2M US Patent Grant and Program Update
- INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
- hTERT US Patent Granted
- Positive SubB2M IHC Results for Melanoma
- IIQ Appendix 4C & Quarterly Activities Report - June 2022
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq